Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000932471-25-001088·AVADEL PHARMACEUTICALS PLC
Schedule 13G ownership disclosure
AVADEL PHARMACEUTICALS PLC
Common Stock · CUSIP: G29687103
Event date: 2025-06-30
- Filing-level shares
- 5,564,259
- Percent of class
- 5.74%
- The Vanguard Group
Shares: 5,564,259 · Class: 5.74%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-001088
- Form type
- SCHEDULE 13G
- Filer
- AVADEL PHARMACEUTICALS PLC
- CIK
- CIK 1012477
- Filed
- Jul 29, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership